H.R.597: Pandemic Treatment Access and Affordability Act of 2021

About This Bill

Bill Version

Bill Summary

Pandemic Treatment Access and Affordability Act of 2021 This bill imposes licensing and price restrictions on federally supported drugs and other medicines intended to address COVID-19 (i.e., coronavirus disease 2019) or other public health emergencies. With respect to a COVID-19 drug patent developed using certain types of federal support, any license granted by the federal government shall be open and nonexclusive. Similarly, a licensee or...

(Source: Library of Congress)

What Lawmakers Are Saying About This Bill

There is one statement associated with H.R.597.

Bill Actions

Date Description
March 22, 2021
Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
Feb. 2, 2021
Referred to the Subcommittee on Health.
Jan. 28, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Science, Space, and Technology, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jan. 28, 2021

Introduced in the House by Jan Schakowsky (D-Ill.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page